Starboard Delivers Letter to Flowserve
Get Alerts FLS Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.2%
Revenue Growth %: -2.5%
Join SI Premium – FREE
Believes Flowserve Is a High-Quality Business Poised to Benefit from Powerful Secular Tailwinds Across Reindustrialization, Power Generation, Nuclear, and Energy Security
Highlights that the Company Has Significantly Underperformed Due to Poor Execution and Details Opportunities to Deliver Improved Shareholder Value
Believes FY30 Targets Are a First Step, and Flowserve Needs to Do Better Faster
Looks Forward to Continuing Constructive Engagement with Board and Management and Plans to Hold Company Accountable
NEW YORK--(BUSINESS WIRE)-- Starboard Value LP (together with its affiliates, “Starboard”), a significant shareholder of Flowserve Corporation (“Flowserve” or the “Company”) (NYSE: FLS), today announced that it has delivered a letter to Flowserve’s Board of Directors, with a copy to the Company’s Chief Executive Officer, R. Scott Rowe, and Chief Financial Officer, Amy Schwetz.
The full text of Starboard's letter to the Company can be viewed here.
About Starboard Value LP
Starboard Value LP is an investment adviser with a focused and differentiated fundamental approach to investing in publicly traded companies. Starboard invests in deeply undervalued companies and actively engages with management teams and boards of directors to identify and execute on opportunities to unlock value for the benefit of all shareholders.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260528563106/en/
Investor contacts:
Peter Feld, (212) 201-4878
Gavin Molinelli, (212) 201-4828
www.starboardvalue.com
Media contacts:
Longacre Square Partners
Joe Germani / Ashley Areopagita, (646) 386-0003
[email protected]
Source: Starboard Value LP
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Downgrades Flowserve Corp. (FLS) to Hold
- Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis
- Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Starboard ValueSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share